Abstract
Introduction

101
Reports of acute flaccid myelitis (AFM) occurring coincident to the outbreak of respiratory 102 disease attributed to EV-D68 raised the possibility that EV-D68 might be the causative 103 agent [7] . EV-D68 infection within a subset of these AFM cases was confirmed in several 104 independent epidemiological clusters in the U.S. [9] [10] [11] [12] [13] [14] [7, 10] . During the 2014 EV-D68 outbreak, patients presenting with AFM showed 109 distinctive magnetic resonance imaging (MRI) findings characterized by brain stem and 110 gray matter longitudinally extensive spinal cord lesions. This matches the findings 111 described in previous outbreaks of EV-A71-associated AFM [9, 19, 20] , suggesting that 112 an enterovirus may be responsible. In support of this hypothesis, Hixon et al. [21] 113 established that several contemporary EV-D68 strains, but not the historically archetypal
114
Fermon and Rhyne EV-D68 strains, can cause a paralytic disease in neonatal mice due 115 to viral infection and killing of spinal cord motor neurons.
117
Phylogenetic analysis reported that many of the 2014 EV-D68 outbreak isolates 118 associated with AFM appeared to belong to the phylogenetic subclade, B1 [10, 22] .
119
Interestingly, 12 substitutions identified in B1 2014 isolates carry the same amino acid or 120 nucleotide residues observed at equivalent positions in other paralysis-causing 121 enteroviruses, including poliovirus and EV-A71 [22] . This suggests that one or more of 122 the nucleotide substitutions present in contemporary EV-D68 strains and lineages and 6 123 not found in historical archetypal strains, may be responsible for the apparent increased 124 incidence of neuropathology associated with the 2014 outbreak. EV-D68 has continued 125 to evolve since the 2014 outbreak, which is unsurprising as mutation and recombination 126 are known to occur in enteroviruses [23, 24] . Sequence analysis has led to the 127 classification of a new clade D (a subclade of A) [25, 26] , and a new subclade, B3, has 128 emerged and quickly expanded [25, 27, 28] (Fig 1C) . However, only the US/MO/47 isolate produced VP1 following infection 211 of the SH-SY5Y neuronal cell line (Fig 1C) , which is consistent with our data on viral 212 replication and CPE (Fig 1A and 1B However, in SH-SY5Y cells, no evidence of HRV infectivity was observed for any strain 277 tested using either the cell viability assay (Fig 3C) all tested D68 strains generated virus following RNA transfection into SH-SY5Y cells.
307
However, the viral titer peaked at 10 4 TCID 50 /ml 48 hours after transfection of SH-SY5Y
308 for viral strains that could not infect SH-SY5Y cells using intact virions (Fig 4) mice were ordered from Envigo and kept in standard housing until the pups were born.
492
At post-natal day 2, the dam and pups were transferred the BioSafety Level 2 (BSL2) series was completed, all plates were removed and RT media was added to each plate.
528
Upon stabilization at RT for 20 min, the manufactures protocol was followed. We 529 validated this deviation from the manufactures protocol by confirming the linearity of the 530 assay across the active range of the study. 
